Self-prescribed Ivermectin use is associated with a lower rate of seroconversion in health care workers diagnosed with COVID, in a dose-dependent response-Reference-Cited by-同舟云学术

Self-prescribed Ivermectin use is associated with a lower rate of seroconversion in health care workers diagnosed with COVID, in a dose-dependent response

Published:2021-07 Issue:4 Volume:25 Page:101603
ISSN:1413-8670
Container-title:The Brazilian Journal of Infectious Diseases
language:en
Short-container-title:The Brazilian Journal of Infectious Diseases

Author:

Pedroso Célia,Vaz Sara^ORCID,Netto Eduardo Martins^ORCID,Souza Daniele,Deminco Felice,Mayoral Rafaela,Menezes Eliana^ORCID,da Cunha Ana Patricia Amancio,Moreira-Soto Andres,Drexler Jan Felix,Brites Carlos^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference16 articles.

1. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro;Caly;Antiviral Res,2020

2. Influence of ivermectin on cellular and humoral immune responses of lambs;Stankiewicz;Vet Immunol Immunopathol,1995

3. Effect of ivermectin on the cellular and humoral immune responses of rabbits;Sajid;Life Sci,2007

4. Severe acute respiratory syndrome coronavirus 2−specific antibody responses in coronavirus disease patients;Okba;Emerg Infect Dis,2020

5. Persisting neutralizing activity to SARS-CoV-2 over months in sera of COVID-19 patients Viruses. 2020 Dec; 12(12): 1357.Published online 2020 Nov 27. doi: 10.3390/v12121357

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and predictors of self-medication to prevent or treat COVID-19 among undergraduate students in Southern Brazil;Anais da Academia Brasileira de Ciências;2024

2. Repurposing antiparasitic drugs for the treatment of other diseases;Advances in Antiparasitic Therapies and Drug Delivery;2024

3. Prevalência do uso de ivermectina para prevenir COVID-19 durante a pandemia em Mato Grosso: estudo transversal de base domiciliar;Revista Brasileira de Epidemiologia;2023

4. Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study;Revista Brasileira de Epidemiologia;2023

5. The (apparent) antibody paradox in COVID-19;Expert Review of Clinical Immunology;2022-03-10